A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results

J. Voortman; E. F. Smit; B. C. Kuenen; H. van de Velde; G. Giaccone

A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results

J. Voortman
, E. F. Smit
, B. C. Kuenen
, H. van de Velde
, G. Giaccone

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	425-425
Journal	European Journal of Cancer. Supplement
Volume	3
Issue number	2
Publication status	Published - Oct 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{9a7e3f4e71d34441af7ceea8b4a5ee08,

title = "A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results",

author = "J. Voortman and Smit, \{E. F.\} and Kuenen, \{B. C.\} and \{van de Velde\}, H. and G. Giaccone",

year = "2005",

month = oct,

language = "English",

volume = "3",

pages = "425--425",

journal = "European Journal of Cancer. Supplement",

issn = "1359-6349",

publisher = "Elsevier Limited",

number = "2",

}

A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results. / Voortman, J.; Smit, E. F.; Kuenen, B. C. et al.
In: European Journal of Cancer. Supplement, Vol. 3, No. 2, 10.2005, p. 425-425.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results

AU - Voortman, J.

AU - Smit, E. F.

AU - Kuenen, B. C.

AU - van de Velde, H.

AU - Giaccone, G.

PY - 2005/10

Y1 - 2005/10

M3 - Meeting Abstract

SN - 1359-6349

VL - 3

SP - 425

EP - 425

JO - European Journal of Cancer. Supplement

JF - European Journal of Cancer. Supplement

IS - 2

ER -